An 8-year-old child with newly diagnosed pulmonary TB (GeneXpert positive, rifampicin-sensitive) is started on standard 4-drug therapy (HRZE). At 2 weeks of therapy, the child remains febrile with persistent cough and shows no clinical improvement. Chest X-ray shows progressive infiltrates. The child is on directly observed therapy (DOT) and adherence is confirmed. What is the most appropriate next step?

Explanation

## Clinical Context This child has microbiologically confirmed, rifampicin-sensitive TB on appropriate first-line therapy with documented adherence but shows clinical deterioration at 2 weeks. This is an unusual presentation and requires systematic investigation before escalating therapy. ## Why Investigate Before Changing Therapy **Key Point:** Treatment failure in pediatric TB is rare with adherent first-line therapy for drug-susceptible disease. Before switching to second-line drugs, the following must be excluded: 1. **Drug malabsorption** — common in children due to: - Diarrhea or malabsorption syndromes - Drug formulation issues (pediatric dosing) - Vomiting or poor palatability 2. **Drug-drug interactions** — especially if child is on: - Antiretrovirals (if HIV-positive) - Anticonvulsants - Other concurrent medications 3. **Alternative or concurrent diagnoses:** - **IRIS** (immune reconstitution inflammatory syndrome) — if child is HIV-positive and recently started ART - **MDR-TB** — despite initial GeneXpert report (rare but possible) - **Non-TB causes** — fungal infection, malignancy, other bacterial infection 4. **Inadequate dosing** — verify weight-based dosing is appropriate **High-Yield:** Clinical deterioration at 2 weeks with confirmed adherence is NOT typical treatment failure; it signals need for diagnostic re-evaluation, not empiric therapy escalation. ## Systematic Approach to Suspected Treatment Failure ```mermaid flowchart TD A[TB on HRZE, deteriorating at 2 weeks]:::outcome --> B{Adherence confirmed?}:::decision B -->|No| C[Reinforce DOT, counsel]:::action B -->|Yes| D[Investigate causes]:::action D --> E[Check drug levels, malabsorption]:::action D --> F[Review for drug interactions]:::action D --> G[Assess for IRIS if HIV+]:::action D --> H[Repeat GeneXpert/culture for MDR]:::action D --> I[Consider alternative diagnosis]:::action E --> J{Cause identified?}:::decision J -->|Yes| K[Correct the cause]:::action J -->|No| L[Consider second-line therapy]:::action ``` **Clinical Pearl:** In pediatric TB, apparent "treatment failure" at 2 weeks is often due to malabsorption, IRIS in HIV-coinfected children, or misdiagnosis rather than true drug resistance. Rushing to second-line therapy without investigation risks unnecessary toxicity and delays correct management. **Mnemonic — Causes of TB Treatment Failure (MAID):** - **M**alabsorption (diarrhea, vomiting) - **A**dherence (confirm DOT) - **I**nteractions (drug-drug, IRIS) - **D**iagnosis (wrong diagnosis, MDR-TB) [cite:Park 26e Ch 5; WHO TB Guidelines 2023]